Search PDMR transactions

Notifier
Name of person with notification obligation
Nicklas Westerholm
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Nicklas Westerholm
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Egetis Therapeutics AB
Issuer´s LEI code
549300RZCKGWRUBPMY22
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share EGETIS THERAPEUTICS AB SE0015193305 Acquisition 6,340 Quantity 5.83 SEK 12/05/2021 Outside a trading venue
Share EGETIS THERAPEUTICS AB SE0015193305 Acquisition 3,950 Quantity 5.82 SEK 14/05/2021 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
EGETIS THERAPEUTICS AB SE0015193305 Acquisition 12/05/2021 Outside a trading venue 6,340 (Quantity) 5.83 SEK
EGETIS THERAPEUTICS AB SE0015193305 Acquisition 14/05/2021 Outside a trading venue 3,950 (Quantity) 5.82 SEK
<< Back